LUDIOMIL

This brand name is authorized in Austria, France, Japan, Poland, South Africa, Spain, Turkey.

Active ingredients

The drug LUDIOMIL contains one active pharmaceutical ingredient (API):

1	Maprotiline UNII 7C8J54PVFI - MAPROTILINE HYDROCHLORIDE
	Maprotiline is a tetracyclic antidepressant, psychoanaleptics, non-selective mono-amine reuptake inhibitor, which shares a number of basic therapeutic properties with the tricyclic antidepressants. It displays a well-balanced spectrum of action, brightening mood and alleviating anxiety, agitation and psychomotor retardation. In masked depression, it can exert a favourable influence on somatic symptoms.
	Read more about Maprotiline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LUDIOMIL Film coated tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AA21	Maprotiline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	51648, 55706
FR	Base de données publique des médicaments	63912862, 67798274
JP	医薬品医療機器総合機構	1179008F1022, 1179008F2029
PL	Rejestru Produktów Leczniczych	100039803, 100039915, 100325621
TR	İlaç ve Tıbbi Cihaz Kurumu	8699708091483, 8699708091490, 8699708091506, 8699708091513, 8699708091520, 8699708091537
ZA	Health Products Regulatory Authority	E/1.2/210, E/1.2/211, E/1.2/212, E/1.2/213, H/1.2/1